Experiences of Using Misoprostol in the Management of Incomplete Abortions: A Voice of Healthcare Workers in Central Malawi

Int J Environ Res Public Health. 2022 Sep 23;19(19):12045. doi: 10.3390/ijerph191912045.

Abstract

Complications after abortion are a major cause of maternal death. Incomplete abortions are common and require treatment with surgical or medical uterine evacuation. Even though misoprostol is a cheaper and safer option, it is rarely used in Malawi. To improve services, an intervention was performed to increase the use of misoprostol in post-abortion care. This study explored healthcare providers' perceptions and experiences with misoprostol in the Malawian setting and their role in achieving effective implementation of the drug. A descriptive phenomenological study was conducted in three hospitals in central Malawi. Focus group discussions were conducted with healthcare workers in centres where the training intervention was offered. Participants were purposefully sampled, and thematic analysis was done. Most of the healthcare workers were positive about the use of misoprostol, knew how to use it and were confident in doing so. The staff preferred misoprostol to surgical treatment because it was perceived safe, effective, easy to use, cost-effective, had few complications, decreased hospital congestion, reduced workload, and saved time. Additionally, misoprostol was administered by nurses/midwives, and not just physicians, thus enhancing task-shifting. The results showed acceptability of misoprostol in post-abortion care among healthcare workers in central Malawi, and further implementation of the drug is recommended.

Keywords: experiences; incomplete abortion; misoprostol; post-abortion care; service providers.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Abortion, Incomplete*
  • Abortion, Induced* / methods
  • Female
  • Health Personnel
  • Humans
  • Malawi
  • Misoprostol* / therapeutic use
  • Pregnancy

Substances

  • Misoprostol

Grants and funding

The study was funded by Helse Nord and The Liaison Committee for education, research, and innovation in Central Norway grant number: (2020/39645) through the Norwegian University of Science and Technology (NTNU) and Malawi University of Science and Technology (MUST).